SAFETY AND TOLERABILITY CHARACTERIZATION OF MARALIXIBAT IN INFANTS WITH ALGS FROM 2 MONTHS OF AGE: INTERIM RESULTS FROM THE RISE STUDY

被引:0
|
作者
Gonzales, Emmanuel [1 ,2 ]
Jankowska, Irena [3 ]
Horslen, Simon P. [4 ]
Ekong, Udeme [5 ]
Rosenthal, Philip [6 ]
Sokal, Etienne [7 ]
Lin, Chuan-Hao [8 ]
Garner, Will [9 ]
Elliott, Jilliann [9 ]
Nunes, Tiago [9 ]
Thompson, Richard J. [10 ]
机构
[1] Univ Paris Saclay, Inserm Umr 1193, Hepatinov, Orsay, France
[2] Univ Paris Saclay, Hop Bicetre, AP HP, Ctr Reference Natl Atresie Voies Biliaires & Chol, Le Kremlin Bicetre, France
[3] Childrens Mem Hlth Inst, Gastroenterol Hepatol Nutr Disorders & Paediat, Warsaw, Poland
[4] UPMC Childrens Hosp Pittsburgh, Pediat, Pittsburgh, PA USA
[5] Medstar Georgetown Univ Hosp, Medstar Georgetown Transplant Inst, Washington, DC USA
[6] Univ Calif San Francisco, Div Pediat Gastroenterol Hepatol & Nutr, Pediat, San Francisco, CA USA
[7] Clin Univ St Luc, Uclouvian, Pediat Hepatol, Brussels, Belgium
[8] Childrens Hosp Angeles, Los Angeles, CA USA
[9] Mirum Pharmaceut Inc, Foster City, CA USA
[10] Kings Coll London, Inst Liver Studies, London, England
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
5021
引用
收藏
页码:E135 / E135
页数:1
相关论文
共 50 条
  • [41] Comparative Safety of Empagliflozin in Routine Care Patients: Interim Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Patorno, Elisabetta
    Tesfaye, Helen
    Wexler, Deborah J.
    Glynn, Robert
    Najafzadeh, Mehdi
    Bessette, Lily G.
    Zakoul, Heidi
    Koeneman, Lisette
    Deruaz-Luyet, Anouk
    Schneeweiss, Sebastian
    DIABETES, 2021, 70
  • [42] Effectiveness and Safety of Empagliflozin in Routine Care Patients: Interim Results from the EMPagliflozin compaRative effectiveness and SafEty (EMPRISE) Study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Bessette, Lily G.
    Franklin, Jessica
    Najafzadeh, Mehdi
    Wexler, Deborah J.
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly
    Schneeweiss, Sebastian
    DIABETES, 2020, 69
  • [43] Effectiveness and safety of empagliflozin in routine care patients: interim results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Patorno, E.
    Pawar, A.
    Bessette, L.
    Franklin, J.
    Najafzadeh, M.
    Wexler, D.
    Deruaz-Luyet, A.
    Brodovicz, K.
    Schneeweiss, S.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S145 - S146
  • [44] Segmental Assessment of Trunk Control in infants from 4 to 9 months of age- a psychometric study
    Pin, Tamis W.
    Butler, Penelope B.
    Cheung, Hon-Ming
    Shum, Sandra Lai-Fong
    BMC PEDIATRICS, 2018, 18
  • [45] Segmental Assessment of Trunk Control in infants from 4 to 9 months of age- a psychometric study
    Tamis W. Pin
    Penelope B. Butler
    Hon-Ming Cheung
    Sandra Lai-Fong Shum
    BMC Pediatrics, 18
  • [46] Nusinersen in Infants who Initiate Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy: Interim Results from the Phase 2 NURTURE Study
    Butterfield, R.
    De Vivo, D.
    Bertini, E.
    Hwu, W-L
    Crawford, T.
    Swoboda, K.
    Finkel, R.
    Kirschner, J.
    Kuntz, N.
    Parsons, J.
    Ryan, M.
    Topaloglu, H.
    Ben Omran, T.
    Sansone, V
    Jong, Y-J
    Shu, F.
    Johnson, K.
    Foster, R.
    Bhan, I
    Fradette, S.
    Farwell, W.
    ANNALS OF NEUROLOGY, 2019, 86 : S117 - S117
  • [47] Efficacy and Safety of Retreatment with Bortezomib in Patients with Multiple Myeloma: Interim Results From RETRIEVE, a Prospective International Phase 2 Study
    Petrucci, Maria Teresa
    Blau, Igor W.
    Corradini, Paolo
    Dimopoulos, Meletios A.
    Drach, Johannes
    Giraldo, Pilar
    Teixeira, Adriana
    Blade, Joan
    BLOOD, 2009, 114 (22) : 1487 - 1488
  • [48] Nusinersen in infants who initiate treatment in a presymptomatic stage of spinal muscular atrophy: interim results from the phase 2 NURTURE study
    Ryan, M.
    De Vivo, D.
    Bertini, E.
    Hwu, W.
    Crawford, T.
    Swoboda, K.
    Finkel, R.
    Kirschner, J.
    Kuntz, N.
    Parsons, J.
    Butterfield, R.
    Topaloglu, H.
    Ben Omran, T.
    Sansone, V.
    Jong, Y.
    Shu, F.
    Foster, R.
    Bhan, I.
    Fradette, S.
    Farwell, W.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S185 - S185
  • [49] EFFICACY AND SAFETY OF RETREATMENT WITH BORTEZOMIB IN PATIENTS WITH MULTIPLE MYELOMA: INTERIM RESULTS FROM RETRIEVE, A PROSPECTIVE INTERNATIONAL PHASE 2 STUDY
    Petrucci, T.
    Blau, I.
    Corradini, P.
    Dimopoulos, M.
    Drach, J.
    Giraldo, P.
    Teixeira, A.
    Ali, M.
    Angermund, R.
    Blade, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 152 - 152
  • [50] Interim doravirine safety results from a pilot switch study for women of childbearing potential in South Africa
    Woods, J.
    Sokhela, S.
    Bosch, B.
    Akpomiemie, G.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 49 - 50